1Papadakis KA.The etiology and pathogenesis of inflammatory bowel disease.Gastroenterol Clinic North Am,1999,28(1):283-296
2Sartor RB.Cytokines in intestinal inflammation:Pathophysiological and clinical considerations.Gastroenterology,1994,106(2):533-539
3Isaacs KL,Sartor RB,Haskill S.Cytokine messager RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification.Gastroenterology,1992,103(5):1587-1595
4Casini-Ragyi V,Lori Kim,Chong YJT,et al.Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease.J Immunol,1995,154(5):2434-2440
5Mitsyma K,Toyonaga A,Sasak E,et al.Soluble IL-6 receptors in inflammatory bowel disease:relation to circulating IL-6.Gut,1995,36(1):45-49
6Ali Keshavarzia,Robert D,Fusunyan,et al.Increased IL-8 in rectal dialysate from patients of the colon.Am J Gastroenterology,1999,94(3):705-712
7Hadziselimovic F,Emmons LR,Gallati H,et al.Souble tumor necrosis factor recerptors P55 and P75 in the urine monitor disease activitiy and the efficacy of treatment of inflammatory bowel disease,Gut,1995,37(2):260-263
8Nikolaos A,Tountas,Casini-Raggi V,et al.Function and ethnic association of allele 2 of the IL-1 receptor antagonist gene in ulceraction colitis.Gastroenterology,1999,117(4):806-813
9Mullin GE,Vezza FR,Sampat A,et al.Abnormal I1-10 mRNA production in the intestinal mucossal lesions of inflammatory bowel disease.Gastroenterology,1993,104(3):A751
10Schreibei S,Heining T,Heining T,et al.Impaired response of activated mononuclear phagocyte to I1-4 in flammatory bowel disease.Gastroenterology,1995,108(1):21-23
